國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Protein instability at interfaces du...

Krause, Mary E.

Protein instability at interfaces during drug product developmentfundamental understanding, evaluation, and mitigation /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Protein instability at interfaces during drug product developmentedited by Jinjiang Li, Mary E. Krause, Raymond Tu.
其他題名:	fundamental understanding, evaluation, and mitigation /
其他作者:	Li, Jinjiang.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	viii, 338 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Drug development.
電子資源:	https://doi.org/10.1007/978-3-030-57177-1
ISBN:	9783030571771$q(electronic bk.)

Protein instability at interfaces during drug product developmentfundamental understanding, evaluation, and mitigation /
Protein instability at interfaces during drug product developmentfundamental understanding, evaluation, and mitigation /[electronic resource] :edited by Jinjiang Li, Mary E. Krause, Raymond Tu. - Cham :Springer International Publishing :2021. - viii, 338 p. :ill., digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,432210-7371 ;. - AAPS advances in the pharmaceutical sciences series ;3..

1. Overview of the impact of protein interfacial instability on the development of biologic products -- 2. Protein adsorption at a gas-aqueous interface -- 3. Interfacial behaviors of proteins -- 4. Interfacial stresses during drug substance purification processes -- 5. Evaluation of interfacial stress during drug product development -- 6.Relating interfacial shear and dilatations stress-es to protein aggregation in mAbs -- 7. Analytical techniques for evaluating protein instability at interfaces -- 8. Analysis of aggregates and particles -- 9. Protein interfacial instability of mixing and lyophilization during drug product manufacturing process scale-up and tech transfer -- 10. Excipients: Characterization, purpose, and selection -- 11. Interfacial stress and proteins prepared in the solid state -- 12. Interfaces in protein drug delivery: device concern -- 13. Future perspectives.

Proteins are exposed to various interfacial stresses during drug product development. They are subjected to air-liquid, liquid-solid, and, sometimes, liquid-liquid interfaces throughout the development cycle-from manufacturing of drug substances to storage and drug delivery. Unlike small molecule drugs, proteins are typically unstable at interfaces where, on adsorption, they often denature and form aggregates, resulting in loss of efficacy and potential immunogenicity. This book covers both the fundamental aspects of proteins at interfaces and the quantification of interfacial behaviors of proteins. Importantly, this book introduces the industrial aspects of protein instabilities at interfaces, including the processes that introduce new interfaces, evaluation of interfacial instabilities, and mitigation strategies. The audience that this book targets encompasses scientists in the pharmaceutical and biotech industry, as well as faculty and students from academia in the surface science, pharmaceutical, and medicinal chemistry areas.

ISBN: 9783030571771$q(electronic bk.)

Standard No.: 10.1007/978-3-030-57177-1doiSubjects--Topical Terms:

190608
Drug development.

LC Class. No.: RM301.25

Dewey Class. No.: 615.19

Protein instability at interfaces during drug product developmentfundamental understanding, evaluation, and mitigation /
LDR:03103nmm a2200337 a 4500 001 600065
003 DE-He213
005 20210419141451.0
006 m d
007 cr nn 008maaau
008 211104s2021 sz s 0 eng d
020 $a 9783030571771$q(electronic bk.)
020 $a 9783030571764$q(paper)
024 7 $a 10.1007/978-3-030-57177-1 $2 doi
035 $a 978-3-030-57177-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .P967 2021
245 0 0 $a Protein instability at interfaces during drug product development $h [electronic resource] : $b fundamental understanding, evaluation, and mitigation / $c edited by Jinjiang Li, Mary E. Krause, Raymond Tu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a viii, 338 p. : $b ill., digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-7371 ; $v 43
505 0 $a 1. Overview of the impact of protein interfacial instability on the development of biologic products -- 2. Protein adsorption at a gas-aqueous interface -- 3. Interfacial behaviors of proteins -- 4. Interfacial stresses during drug substance purification processes -- 5. Evaluation of interfacial stress during drug product development -- 6.Relating interfacial shear and dilatations stress-es to protein aggregation in mAbs -- 7. Analytical techniques for evaluating protein instability at interfaces -- 8. Analysis of aggregates and particles -- 9. Protein interfacial instability of mixing and lyophilization during drug product manufacturing process scale-up and tech transfer -- 10. Excipients: Characterization, purpose, and selection -- 11. Interfacial stress and proteins prepared in the solid state -- 12. Interfaces in protein drug delivery: device concern -- 13. Future perspectives.
520 $a Proteins are exposed to various interfacial stresses during drug product development. They are subjected to air-liquid, liquid-solid, and, sometimes, liquid-liquid interfaces throughout the development cycle-from manufacturing of drug substances to storage and drug delivery. Unlike small molecule drugs, proteins are typically unstable at interfaces where, on adsorption, they often denature and form aggregates, resulting in loss of efficacy and potential immunogenicity. This book covers both the fundamental aspects of proteins at interfaces and the quantification of interfacial behaviors of proteins. Importantly, this book introduces the industrial aspects of protein instabilities at interfaces, including the processes that introduce new interfaces, evaluation of interfacial instabilities, and mitigation strategies. The audience that this book targets encompasses scientists in the pharmaceutical and biotech industry, as well as faculty and students from academia in the surface science, pharmaceutical, and medicinal chemistry areas.
650 0 $a Drug development. $3 190608
650 0 $a Proteins $x Therapeutic use. $3 225255
650 0 $a Biological interfaces. $3 203100
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Pharmacy. $3 218145
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Theoretical and Computational Chemistry. $3 273882
650 2 4 $a Biotechnology. $3 188829
700 1 $a Li, Jinjiang. $3 894519
700 1 $a Krause, Mary E. $3 894520
700 1 $a Tu, Raymond. $3 894521
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 559046
856 4 0 $u https://doi.org/10.1007/978-3-030-57177-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)